ES2071303T3 - Compuestos homologados de vitamina d2 y los derivados hidroxilados en 1alfa correspondientes. - Google Patents

Compuestos homologados de vitamina d2 y los derivados hidroxilados en 1alfa correspondientes.

Info

Publication number
ES2071303T3
ES2071303T3 ES91905084T ES91905084T ES2071303T3 ES 2071303 T3 ES2071303 T3 ES 2071303T3 ES 91905084 T ES91905084 T ES 91905084T ES 91905084 T ES91905084 T ES 91905084T ES 2071303 T3 ES2071303 T3 ES 2071303T3
Authority
ES
Spain
Prior art keywords
vitamin
alpha
hydroxylated derivatives
approved compounds
corresponding hydroxylated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91905084T
Other languages
English (en)
Inventor
Hector Floyd Deluca
Heinrich Konstantine Schnoes
Kato Leonard Perlman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wisconsin Alumni Research Foundation
Original Assignee
Wisconsin Alumni Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Research Foundation filed Critical Wisconsin Alumni Research Foundation
Application granted granted Critical
Publication of ES2071303T3 publication Critical patent/ES2071303T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

ESTA INVENCION SE REFIERE A NUEVOS COMPUESTOS DE VITAMINA D2 HOMOLOGADOS 24, 26 Y/O 27, COMO 26, 27-DIHOMO-1 ALFA-HIDROXIVITAMINA D2, 26, 27-DIHOMO-1 ALFA-HIDROXI-24-EPI-VITAMINA D2, 26, 27 -DIHOMO-1 ALFA, 25-DIHIDROXI-24-EPI-VITAMINA D2 Y CIERTOS DERIVADOS SUYOS HIDROXI-PROTEGIDOS. LOS NUEVOS COMPUESTOS EPI MUESTRAN EN ESPECIAL UN PATRON DE ACTIVIDAD DISTINTIVO QUE COMPRENDE UNA ALTA POTENCIA PARA LA ESTIMULACION DEL TRANSPORTE DE CALCIO INTESTINAL Y POCA O NINGUNA ACTIVIDAD PARA INDUCIR LA MOVILIZACION DEL CALCIO EN LOS HUESOS O DIFERENCIAR CELULAS NO DIFERENCIADAS EN CULTIVO, MOSTRANDO ASI SU UTILIDAD PARA EL TRATAMIENTO DE ENFERMEDADES CARACTERIZADAS POR LA PERDIDA DE MASA OSEA. EN CONTRASTE, LA FORMA NATURAL NO MUESTRA ACTIVIDAD NI EN LA MOVILIZACION DEL CALCIO DE LOS HUESOS O EN LA ESTIMULACION DEL TRANSPORTE DE CALCIO INTESTINAL. TAMBIEN SE DESCRIBE UN PROCESO PARA PREPARAR ESTOS COMPUESTOS.
ES91905084T 1990-02-14 1991-02-13 Compuestos homologados de vitamina d2 y los derivados hidroxilados en 1alfa correspondientes. Expired - Lifetime ES2071303T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/481,990 US5030772A (en) 1990-02-14 1990-02-14 Process for preparing vitamin D2 compounds and the corresponding 1 α-hydroxylated derivatives

Publications (1)

Publication Number Publication Date
ES2071303T3 true ES2071303T3 (es) 1995-06-16

Family

ID=23914203

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91905084T Expired - Lifetime ES2071303T3 (es) 1990-02-14 1991-02-13 Compuestos homologados de vitamina d2 y los derivados hidroxilados en 1alfa correspondientes.

Country Status (7)

Country Link
US (1) US5030772A (es)
EP (1) EP0468042B1 (es)
JP (1) JP2731839B2 (es)
AT (1) ATE121387T1 (es)
DE (1) DE69109006T2 (es)
ES (1) ES2071303T3 (es)
WO (1) WO1991012239A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3933034A1 (de) * 1989-10-02 1991-04-11 Schering Ag 24-homo-vitamin-d-derivate, verfahren zu ihrer herstellung
IL104201A0 (en) * 1991-12-26 1993-05-13 Wisconsin Alumni Res Found 26,27-dimethylene-1 alpha-25-dihydroxyvitamin d2 and its 24-epimer and pharmaceutical compositions containing them
US5716946A (en) * 1996-02-13 1998-02-10 Wisconsin Alumni Research Foundation Multiple sclerosis treatment
AU755701B2 (en) * 1998-05-29 2002-12-19 Bone Care International, Inc. Method for making hydroxy-25-ene-vitamin D compounds
US6479474B2 (en) 1999-07-08 2002-11-12 Wisconsin Alumni Research Foundation Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis
US7094775B2 (en) 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
US20060003950A1 (en) * 2004-06-30 2006-01-05 Bone Care International, Inc. Method of treating prostatic diseases using a combination of vitamin D analogues and other agents
WO2006051106A1 (en) 2004-11-12 2006-05-18 Bioxell Spa Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer
US7745226B2 (en) 2005-04-06 2010-06-29 Quest Diagnostics Investments Incorporated Methods for detecting vitamin D metabolites
US7972868B2 (en) 2007-11-28 2011-07-05 Quest Diagnostics Investments Incorporated Methods for detecting dihydroxyvitamin D metabolites by mass spectrometry
CN107019795A (zh) * 2009-01-27 2017-08-08 博格有限责任公司 用于减轻与化疗有关的副作用的维生素d3化合物
MX366076B (es) 2009-08-14 2019-06-27 Berg Llc Vitamina d3 y analogos de la misma para tratar alopecia.
US7977117B2 (en) 2009-12-03 2011-07-12 Quest Diagnostics Investments Incorprated Vitamin D metabolite determination utilizing mass spectrometry following derivatization
CA2783797C (en) 2009-12-11 2021-06-08 Quest Diagnostics Investments Incorporated Mass spectrometric determination of non-derivatized, non-metabolized vitamin d
CA2783708C (en) 2009-12-11 2018-09-18 Quest Diagnostics Investments Incorporated Mass spectrometry of steroidal compounds in multiplex samples
NZ714801A (en) 2013-05-29 2021-07-30 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin d

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3585221A (en) * 1969-03-24 1971-06-15 Wisconsin Alumni Res Found 25-hydroxyergocalciferol
US3880894A (en) * 1974-05-24 1975-04-29 Wisconsin Alumni Res Found 1,25-Dihydroxyergocalciferol
JPS51108049A (en) * 1975-03-17 1976-09-25 Teijin Ltd 1 arufua * 24 * s * *255 torihidorokishikorekarushifuerooruno seizoho
JPS51108046A (en) * 1975-03-17 1976-09-25 Teijin Ltd 1 arufua * 24 * r * *255 torihidorokishikorekarushifuerooruno seizoho
JPS51108048A (en) * 1975-03-17 1976-09-25 Teijin Ltd 1 arufua * 24 * s * *255 torihidokishikorekarushifuerooruno seizoho
US4260549A (en) * 1979-05-21 1981-04-07 Wisconsin Alumni Research Foundation Process for preparing 1α-hydroxylated compounds
US4226787A (en) * 1978-07-26 1980-10-07 Wisconsin Alumni Research Foundation Fluorovitamin D compounds and processes for their preparation
US4448721A (en) * 1982-09-20 1984-05-15 Wisconsin Alumni Research Foundation Hydroxyvitamin D2 compounds and process for preparing same
GB2139627B (en) * 1983-05-09 1987-02-04 Wisconsin Alumni Res Found 1 25-dihydroxylated vitamin d2 compounds and intermediates in the preparation thereof
US4769181A (en) * 1983-11-07 1988-09-06 Wisconsin Alumni Research Foundation 1,25-dihydroxyvitamin D2 compounds
DE3590080C2 (es) * 1984-03-05 1992-08-06 Wisconsin Alumni Research Foundation, Madison, Wis., Us
US4588528A (en) * 1984-05-31 1986-05-13 Wisconsin Alumni Research Foundation 1,24-dihydroxy-Δ22 -vitamin D3 and process for preparing same
NL8520265A (nl) * 1984-10-04 1986-09-01 Wisconsin Alumni Res Found Derivaten van vitamine d en werkwijzen voor het bereiden daarvan.
US4554106A (en) * 1984-11-01 1985-11-19 Wisconsin Alumni Research Foundation Method for preparing 1α-hydroxyvitamin D compounds
WO1986004333A1 (en) * 1985-01-17 1986-07-31 Wisconsin Alumni Research Foundation Vitamin d derivatives and methods for preparing same
JPS62501505A (ja) * 1985-01-17 1987-06-18 ウイスコンシン　アラムナイ　リサ−チ　フオンデ−シヨン ビタミンｄ誘導体
AU614372B2 (en) * 1988-04-21 1991-08-29 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Novel vitamin d analogues
AU629831B2 (en) * 1988-04-29 1992-10-15 Wisconsin Alumni Research Foundation Side chain unsaturated 1 alpha-hydroxyvitamin d homologs for the treatment of leukemia
US4847012A (en) * 1988-04-29 1989-07-11 Wisconsin Alumni Research Foundation Vitamin D related compounds and processes for their preparation
US4973584A (en) * 1989-03-09 1990-11-27 Deluca Hector F Novel 1α-hydroxyvitamin D2 epimer and derivatives
EP0402982B1 (en) * 1989-06-15 1994-01-05 Duphar International Research B.V Adduct-aldehyde and its use for the preparation of a vitamin-D compound
GB8914963D0 (en) * 1989-06-29 1989-08-23 Leo Pharm Prod Ltd Chemical compounds
DE3933034A1 (de) * 1989-10-02 1991-04-11 Schering Ag 24-homo-vitamin-d-derivate, verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
JP2731839B2 (ja) 1998-03-25
DE69109006D1 (de) 1995-05-24
WO1991012239A1 (en) 1991-08-22
US5030772A (en) 1991-07-09
JPH04505468A (ja) 1992-09-24
ATE121387T1 (de) 1995-05-15
EP0468042A1 (en) 1992-01-29
DE69109006T2 (de) 1995-08-31
EP0468042B1 (en) 1995-04-19

Similar Documents

Publication Publication Date Title
ES2071303T3 (es) Compuestos homologados de vitamina d2 y los derivados hidroxilados en 1alfa correspondientes.
ES2046383T3 (es) Nuevos derivados de acidos difosfonicos, procedimientos para su preparacion y medicamentos que contienen estos compuestos.
FI895213A0 (fi) Foereningar avsedda foer vaord av alzheimers sjukdom.
MX9201419A (es) Derivados de benzo isoxazol-piperidina.
NO179518C (no) AnalogifremgangsmÕte for fremstilling av 2- hydroksymetylcytosin-substituerte 1,3-oksatiolaner
ES513391A0 (es) Procedimiento para la obtencion de 2-aril-3,4-diazabiciclo 4.n.0-alq-2-en-5-onas.
EE02979B1 (et) Formoterool ja tema ühendid ning nende valmistamise meetod
MX13270A (es) Procedimiento para la preparacion de derivados de 4-aminopiridina
ES2086065T3 (es) Preparacion de tetrahidropiridinas sustituidas.
EE03027B1 (et) Meetod 8-klorokinolooni derivaatide valmistamiseks
ES2072332T3 (es) Derivados de la dibenzo(1,5)dioxocin-5-ona, su uso en medicamentos y procedimiento para su fabricacion.
NO180537C (no) Fremgangsmåte for fremstilling av vitamin D2-forbindelser og de tilsvarende <alfa>-hydroksylerte derivater
ES2082890T3 (es) Procedimiento para la preparacion de derivados 6-(aminopropionilo sustituido) de forskolina.
ES2089176T3 (es) Procedimiento para la preparacion de carboditioatos de piperidina fluorometil-sustituidos.
ES2067621T3 (es) Procedimiento para la preparacion de compuestos molusquicidas de 2,4,5-tribromopirrol-3-carbonitrilo.
FR2684102B1 (fr) Procede de preparation de polyazidoalcools ainsi que de polyaminoalcools et polyazidothiols derives de ceux-ci.
FR2618781B2 (fr) Procede de preparation de derives de la 4,4-dimethyl tetrahydro pyr-2-one
FR2647450B1 (fr) Procede de preparation des derives de 2(prime), 3(prime)-dideshydro-2(prime),3(prime)-didesoxynucleoside
OA09202A (fr) Procédé de préparation des nouveaux dérivés de la thiéno-triazolo-diazépine.
FR2661911B1 (fr) Procede de preparation de derives de la thieno-triazolo-diazepine.
DZ1415A1 (fr) Procédé de préparation de dérivés de la thiéno-triazolo-diazépine.
OA09208A (fr) "Procédé de préparation de dérivés de la thiéno-triazolo-diazépine".
NO171565C (no) Fremgangsmaate for behandling av manganslam
NO950203D0 (no) Fremgangsmåte for fremstilling av propargylazetidion-forbindelser
GR900100297A (en) Cylinder for the treatment of furs

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 468042

Country of ref document: ES